An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
DR Owen, CMN Allerton, AS Anderson… - Science, 2021 - science.org
The worldwide outbreak of COVID-19 caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has become a global pandemic. Alongside vaccines, antiviral …
coronavirus 2 (SARS-CoV-2) has become a global pandemic. Alongside vaccines, antiviral …
The promise and peril of chemical probes
…, DR Owen, SH Rosenberg, R Ross… - Nature chemical …, 2015 - nature.com
Chemical probes are powerful reagents with increasing impacts on biomedical research.
However, probes of poor quality or that are used incorrectly generate misleading results. To …
However, probes of poor quality or that are used incorrectly generate misleading results. To …
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis
…, MP Edwards, VA Horne, AM Correia, DR Owen… - Bioorganic & medicinal …, 2009 - Elsevier
A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium
templates 2a–b, and Sulfonamide derivatives 11a–n …
templates 2a–b, and Sulfonamide derivatives 11a–n …
PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains
Bromo and extra terminal (BET) proteins (BRD2, BRD3, BRD4, and BRDT) are transcriptional
regulators required for efficient expression of several growth promoting and antiapoptotic …
regulators required for efficient expression of several growth promoting and antiapoptotic …
The SMARCA2/4 ATPase domain surpasses the bromodomain as a drug target in SWI/SNF-mutant cancers: insights from cDNA rescue and PFI-3 inhibitor studies
…, C Toniatti, A Petrocchi, D Verhelle, DR Owen… - Cancer research, 2015 - AACR
The SWI/SNF multisubunit complex modulates chromatin structure through the activity of
two mutually exclusive catalytic subunits, SMARCA2 and SMARCA4, which both contain a …
two mutually exclusive catalytic subunits, SMARCA2 and SMARCA4, which both contain a …
Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit
The posttranslational modification of chromatin through acetylation at selected histone
lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (…
lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (…
Enantioselective catalytic intramolecular cyclopropanation using modified cinchona alkaloid organocatalysts.
…, N Bremeyer, SV Ley, DR Owen… - … (International ed. in …, 2006 - europepmc.org
… Reissig HU, Zimmer R … R. Fieldhouse (Zeneca Agrochemicals) for their interest and
support of this work. … Luo J, Chen R, Fan X, Gong J, Han J, He Z …
support of this work. … Luo J, Chen R, Fan X, Gong J, Han J, He Z …
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells
…, PJ Brown, ME Bunnage, DR Owen… - Proceedings of the …, 2014 - National Acad Sciences
SET domain containing (lysine methyltransferase) 7 (SETD7) is implicated in multiple
signaling and disease related pathways with a broad diversity of reported substrates. Here, we …
signaling and disease related pathways with a broad diversity of reported substrates. Here, we …
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance
O Fedorov, J Castex, C Tallant, DR Owen, S Martin… - Science …, 2015 - science.org
Mammalian SWI/SNF [also called Brg/Brahma-associated factors (BAFs)] are evolutionarily
conserved chromatin-remodeling complexes regulating gene transcription programs during …
conserved chromatin-remodeling complexes regulating gene transcription programs during …
[PDF][PDF] SETD7 controls intestinal regeneration and tumorigenesis by regulating Wnt/β-catenin and Hippo/YAP signaling
Intestinal tumorigenesis is a result of mutations in signaling pathways that control cellular
proliferation, differentiation, and survival. Mutations in the Wnt/β-catenin pathway are …
proliferation, differentiation, and survival. Mutations in the Wnt/β-catenin pathway are …